Biotech | March 18, 2022
Sanofi moves forward with EUROAPI listing on Euronext Paris
EUROAPI listing on Euronext Paris will occur in H1 2022, despite volatile market conditions
EUROAPI listing on Euronext Paris will occur in H1 2022, despite volatile market conditions
SIFI is currently evaluating various options for the commercialization of Akantior (polihexanide) globally, including potential out-license agreements outside its core markets
Ritika has also extensively worked with clients such as WHO, GAVI Alliance, USAID, Gilead, Novartis, Sanofi Pasteur
The primary objective of this Phase 1 study is to investigate the safety and tolerability of GZR18 in healthy volunteers
The product will be manufactured at Lupin’s facility in Goa, India
Partners with GITAM University to train 27 employees through a 10-day HR module and make them future-ready
Price was the key driver for the period
The approval marks the first-and-only immunotherapy-based treatment for use before surgery for non-small cell lung cancer
First of three Amneal biosimilars expected for U.S. approval and launch in 2022
In this role, Jeffrey DeAlmeida takes responsibility for BASF’s global pharmaceutical solutions portfolio and the Nutrition & Health business in North and South America
Subscribe To Our Newsletter & Stay Updated
